Nothing Special   »   [go: up one dir, main page]

Han et al., 2016 - Google Patents

The further characterization of the peptide specifically binding to gastric cancer

Han et al., 2016

Document ID
12275075217102826161
Author
Han J
Gao X
Duan W
Lin F
Nie G
Xue Q
Huang Y
Duan Y
Wang Q
Hou Y
Publication year
Publication venue
Molecular and cellular probes

External Links

Snippet

Targeting peptide has been considered to be useful as a small molecule probe leading to multifunctional properties for both imaging detection and targeting therapy. Thus, the identification of novel targets is urgently needed to develop innovative agents to effectively …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Liu et al. Tumor-targeting peptides from combinatorial libraries
Kelly et al. Isolation of a colon tumor specific binding peptide using phage display selection
US20190209715A1 (en) Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma
Zhang et al. Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach
CN101389963A (en) Vascular tumor markers
Xiao et al. Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
Ma et al. A novel peptide specifically targeting ovarian cancer identified by in vivo phage display
Zhou et al. A novel near-infrared fluorescent probe TMTP1-PEG4-ICG for in vivo tumor imaging
CN107286222B (en) Polypeptide of targeted tumor stem cell marker CD133 and application thereof
Xiao et al. Development of a novel drug targeting delivery system for cervical cancer therapy
CN107073065B (en) Peptide reagents and methods for detection and targeting of dysplasia, early stage cancer, and cancer
Yang et al. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo
US8541543B2 (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
US11406720B2 (en) Fibroblast growth factor receptor 2-specific peptide reagents and methods
Han et al. The further characterization of the peptide specifically binding to gastric cancer
Guo et al. Screening and identification of a specific peptide binding to hepatocellular carcinoma cells from a phage display peptide library
Ma et al. Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library
WO2014002836A1 (en) Egfr-binding peptide
CN108697756B (en) HER2 peptide reagents and methods
Sturzu et al. Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging
US20180052165A1 (en) Claudin-1 peptide reagents and methods
Yang et al. One-bead one-compound combinatorial library derived targeting ligands for detection and treatment of oral squamous cancer
Passarella et al. Recombinant peptides as biomarkers for tumor response to molecular targeted therapy
EP3611181A1 (en) Atp1a1-targeting polypeptide and use
Jin et al. Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library